Nalaganje...
Targeting the Programmed Death-1 Pathway in Lymphoid Neoplasms
Programmed death-1 (PD-1) is a co-inhibitory molecule and is seen in CD4+ and CD8+ T cells. Upon binding to its ligands, programmed death ligand-1 (PD-L1) and -2 (PD-L2), PD-1 negatively regulates interleukin 2 (IL-2) production and T cell proliferation. Activated effector T-cells, which kill cancer...
Shranjeno v:
| izdano v: | Cancer Treat Rev |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5815314/ https://ncbi.nlm.nih.gov/pubmed/28242522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2017.01.009 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|